NCCN GUIDELINES
            ® INSIGHTS CE Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024

Joyce Liu; Andrew Berchuck; Floor J. Backes; Joshua Cohen; Rachel Grisham; Charles A. Leath; Lainie Martin; Daniela Matei; David S. Miller; Sharon Robertson; Lisa Barroilhet; Shitanshu Uppal; Andrea Wahner Hendrickson; David M. Gershenson; Heidi J. Gray; Ardeshir Hakam; Angela Jain; Gottfried E. Konecny; John Moroney; Elena Ratner; John Schorge; Premal H. Thaker; Theresa L. Werner; Emese Zsiros; Kian Behbakht; Lee May Chen; Marie DeRosa; Eric L. Eisenhauer; Gary Leiserowitz; Babak Litkouhi; Michael McHale; Sanja Percac-Lima; Kerry Rodabaugh; Roberto Vargas; Frankie Jones; Emily Kovach; Lisa Hang; Swathi Ramakrishnan; Ronald D. Alvarez; Deborah K. Armstrong

doi:10.6004/jnccn.2024.0052

NCCN GUIDELINES ^® INSIGHTS CE Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024

Joyce Liu
, Andrew Berchuck
, Floor J. Backes
, Joshua Cohen
, Rachel Grisham
, Charles A. Leath
, Lainie Martin
, Daniela Matei
, David S. Miller
, Sharon Robertson
, Lisa Barroilhet
, Shitanshu Uppal
, Andrea Wahner Hendrickson
, David M. Gershenson
, Heidi J. Gray
, Ardeshir Hakam
, Angela Jain
, Gottfried E. Konecny
, John Moroney
, Elena Ratner

John Schorge, Premal H. Thaker, Theresa L. Werner, Emese Zsiros, Kian Behbakht, Lee May Chen, Marie DeRosa, Eric L. Eisenhauer, Gary Leiserowitz, Babak Litkouhi, Michael McHale, Sanja Percac-Lima, Kerry Rodabaugh, Roberto Vargas, Frankie Jones, Emily Kovach, Lisa Hang, Swathi Ramakrishnan, Ronald D. Alvarez, Deborah K. Armstrong

Dana-Farber/Brigham and Women's Cancer Center
Duke University
Ohio State University
City of Hope National Medical Center
Memorial Sloan-Kettering Cancer Center
O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham
University of Pennsylvania
Northwestern University
UT Southwestern Simmons Comprehensive Cancer Center
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
University of Wisconsin Carbone Cancer Center
University of Michigan Rogel Cancer Center
Mayo Clinic Comprehensive Cancer Center
University of Texas MD Anderson Cancer Center
Fred Hutchinson Cancer Research Center
Moffitt Cancer Center
Fox Chase Cancer Center
University of California at Los Angeles
UChicago Medicine Comprehensive Cancer Center
Yale Cancer Center/Smilow Cancer Hospital
University of Tennessee Health Science Center
University of Washington
University of Utah
University of Colorado Cancer Center
UCSF Helen Diller Family Comprehensive Cancer Center
Mass General Cancer Center
UC Davis Comprehensive Cancer Center
Stanford Cancer Institute
University of California at San Diego
Fred & Pamela Buffett Cancer Center
Cleveland Clinic Foundation
National Comprehensive Cancer Network
Vanderbilt-Ingram Cancer Center
Sidney Kimmel Comprehensive Cancer Center

Research output: Contribution to journal › Article › peer-review

122 Scopus citations

Abstract

The NCCN Guidelines for Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer provide multidisciplinary diagnostic workup, staging, and treatment recommendations for this disease. These NCCN Guidelines Insights detail how the evolution of the use of PARP inhibitors as maintenance and single-agent regimens for the treatment of ovarian cancer informed panel recommendations in the guidelines.

Original language	English
Pages (from-to)	512-519
Number of pages	8
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	22
Issue number	8
DOIs	https://doi.org/10.6004/jnccn.2024.0052
State	Published - Oct 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Fallopian Tube Neoplasms/diagnosis
Female
Humans
Medical Oncology/standards
Neoplasm Staging
Ovarian Neoplasms/diagnosis
Peritoneal Neoplasms/therapy
Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use

Access to Document

10.6004/jnccn.2024.0052

Cite this

Liu, J., Berchuck, A., Backes, F. J., Cohen, J., Grisham, R., Leath, C. A., Martin, L., Matei, D., Miller, D. S., Robertson, S., Barroilhet, L., Uppal, S., Hendrickson, A. W., Gershenson, D. M., Gray, H. J., Hakam, A., Jain, A., Konecny, G. E., Moroney, J., ... Armstrong, D. K. (2024). NCCN GUIDELINES ^® INSIGHTS CE Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024. JNCCN Journal of the National Comprehensive Cancer Network, 22(8), 512-519. https://doi.org/10.6004/jnccn.2024.0052

@article{da9322b509e6485e9285104e89bf7cbc,

title = "NCCN GUIDELINES {\textregistered} INSIGHTS CE Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024",

abstract = "The NCCN Guidelines for Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer provide multidisciplinary diagnostic workup, staging, and treatment recommendations for this disease. These NCCN Guidelines Insights detail how the evolution of the use of PARP inhibitors as maintenance and single-agent regimens for the treatment of ovarian cancer informed panel recommendations in the guidelines.",

keywords = "Fallopian Tube Neoplasms/diagnosis, Female, Humans, Medical Oncology/standards, Neoplasm Staging, Ovarian Neoplasms/diagnosis, Peritoneal Neoplasms/therapy, Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use",

author = "Joyce Liu and Andrew Berchuck and Backes, \{Floor J.\} and Joshua Cohen and Rachel Grisham and Leath, \{Charles A.\} and Lainie Martin and Daniela Matei and Miller, \{David S.\} and Sharon Robertson and Lisa Barroilhet and Shitanshu Uppal and Hendrickson, \{Andrea Wahner\} and Gershenson, \{David M.\} and Gray, \{Heidi J.\} and Ardeshir Hakam and Angela Jain and Konecny, \{Gottfried E.\} and John Moroney and Elena Ratner and John Schorge and Thaker, \{Premal H.\} and Werner, \{Theresa L.\} and Emese Zsiros and Kian Behbakht and Chen, \{Lee May\} and Marie DeRosa and Eisenhauer, \{Eric L.\} and Gary Leiserowitz and Babak Litkouhi and Michael McHale and Sanja Percac-Lima and Kerry Rodabaugh and Roberto Vargas and Frankie Jones and Emily Kovach and Lisa Hang and Swathi Ramakrishnan and Alvarez, \{Ronald D.\} and Armstrong, \{Deborah K.\}",

note = "Publisher Copyright: {\textcopyright} JNCCN.",

year = "2024",

month = oct,

doi = "10.6004/jnccn.2024.0052",

language = "English",

volume = "22",

pages = "512--519",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "8",

}

Liu, J, Berchuck, A, Backes, FJ, Cohen, J, Grisham, R, Leath, CA, Martin, L, Matei, D, Miller, DS, Robertson, S, Barroilhet, L, Uppal, S, Hendrickson, AW, Gershenson, DM, Gray, HJ, Hakam, A, Jain, A, Konecny, GE, Moroney, J, Ratner, E, Schorge, J, Thaker, PH, Werner, TL, Zsiros, E, Behbakht, K, Chen, LM, DeRosa, M, Eisenhauer, EL, Leiserowitz, G, Litkouhi, B, McHale, M, Percac-Lima, S, Rodabaugh, K, Vargas, R, Jones, F, Kovach, E, Hang, L, Ramakrishnan, S, Alvarez, RD & Armstrong, DK 2024, 'NCCN GUIDELINES ^® INSIGHTS CE Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024', JNCCN Journal of the National Comprehensive Cancer Network, vol. 22, no. 8, pp. 512-519. https://doi.org/10.6004/jnccn.2024.0052

TY - JOUR

T1 - NCCN GUIDELINES ® INSIGHTS CE Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024

AU - Liu, Joyce

AU - Berchuck, Andrew

AU - Backes, Floor J.

AU - Cohen, Joshua

AU - Grisham, Rachel

AU - Leath, Charles A.

AU - Martin, Lainie

AU - Matei, Daniela

AU - Miller, David S.

AU - Robertson, Sharon

AU - Barroilhet, Lisa

AU - Uppal, Shitanshu

AU - Hendrickson, Andrea Wahner

AU - Gershenson, David M.

AU - Gray, Heidi J.

AU - Hakam, Ardeshir

AU - Jain, Angela

AU - Konecny, Gottfried E.

AU - Moroney, John

AU - Ratner, Elena

AU - Schorge, John

AU - Thaker, Premal H.

AU - Werner, Theresa L.

AU - Zsiros, Emese

AU - Behbakht, Kian

AU - Chen, Lee May

AU - DeRosa, Marie

AU - Eisenhauer, Eric L.

AU - Leiserowitz, Gary

AU - Litkouhi, Babak

AU - McHale, Michael

AU - Percac-Lima, Sanja

AU - Rodabaugh, Kerry

AU - Vargas, Roberto

AU - Jones, Frankie

AU - Kovach, Emily

AU - Hang, Lisa

AU - Ramakrishnan, Swathi

AU - Alvarez, Ronald D.

AU - Armstrong, Deborah K.

PY - 2024/10

Y1 - 2024/10

N2 - The NCCN Guidelines for Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer provide multidisciplinary diagnostic workup, staging, and treatment recommendations for this disease. These NCCN Guidelines Insights detail how the evolution of the use of PARP inhibitors as maintenance and single-agent regimens for the treatment of ovarian cancer informed panel recommendations in the guidelines.

AB - The NCCN Guidelines for Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer provide multidisciplinary diagnostic workup, staging, and treatment recommendations for this disease. These NCCN Guidelines Insights detail how the evolution of the use of PARP inhibitors as maintenance and single-agent regimens for the treatment of ovarian cancer informed panel recommendations in the guidelines.

KW - Fallopian Tube Neoplasms/diagnosis

KW - Female

KW - Humans

KW - Medical Oncology/standards

KW - Neoplasm Staging

KW - Ovarian Neoplasms/diagnosis

KW - Peritoneal Neoplasms/therapy

KW - Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use

UR - https://www.scopus.com/pages/publications/85206641233

U2 - 10.6004/jnccn.2024.0052

DO - 10.6004/jnccn.2024.0052

M3 - Article

C2 - 39413835

AN - SCOPUS:85206641233

SN - 1540-1405

VL - 22

SP - 512

EP - 519

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 8

ER -